ERBB2 heterogeneity is one of the factors affecting diagnosis; it is characterized by differential expression or amplification within the same tumor (intratumoral) or in cancers from various sites or time points in the same patient (intertumoral) [72]. This evidence concerns the gene ERBB2 and cancer.